Back
Recursion Pharmaceuticals Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
49
RXRX
Recursion Pharmaceuticals
Last Price:
$5.49
Seasonality Move:
-5.87%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight selling pressure.
Recursion Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.19 | Buy |
20-day SMA: | 5.13 | Buy |
50-day SMA: | 4.89 | Buy |
200-day SMA: | 6.3 | Sell |
8-day EMA: | 5.16 | Buy |
20-day EMA: | 5.06 | Buy |
50-day EMA: | 5.1 | Buy |
200-day EMA: | 6.21 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 55.16 | Buy |
Chaikin Money Flow: | 5527369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Recursion Pharmaceuticals Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 5.27 while RXRX 8-day simple moving average is 5.19, which is a Buy signal.
-
The stock price of RXRX is 5.27 while Recursion Pharmaceuticals 20-day SMA is 5.13, which makes it a Buy.
-
Recursion Pharmaceuticals 50-day simple moving average is 4.89 while RXRX share price is 5.27, making it a Buy technically.
-
RXRX stock price is 5.27 and Recursion Pharmaceuticals 200-day simple moving average is 6.30, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
49
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $5.27. The Score for RXRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.1B
Price in USD:
5.27
Share Volume:
16.6M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
12.36
52-Week Low:
3.79
Sell
49
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 5.27 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 5.27 while RXRX 8-day exponential moving average is 5.16, which is a Buy signal.
-
The stock price of RXRX is 5.27 while Recursion Pharmaceuticals 20-day EMA is 5.06, which makes it a Buy.
-
Recursion Pharmaceuticals 50-day exponential moving average is 5.10 while RXRX share price is 5.27, making it a Buy technically.
-
RXRX stock price is 5.27 and Recursion Pharmaceuticals 200-day simple moving average is 6.21, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Recursion Pharmaceuticals is a Buy
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 55.16, which suggest Recursion Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is ( - ), which suggest Recursion Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is ( - ), which suggest Recursion Pharmaceuticals is a Buy
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.